DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Analysts maintain a “Hold” consensus on DENTSPLY SIRONA, with three sell, nine hold, and three buy ratings. The average 12-month price target is $13.54, above the stock’s reported $10.76 price.
• The company’s latest quarterly results exceeded expectations, with adjusted EPS of $0.52 versus a $0.35 consensus estimate and revenue of $898 million. However, revenue declined 4.1% year over year, and the company reported a negative net margin.
• Insiders purchased 35,160 shares worth approximately $351,179 during the quarter, while institutional investors—including California State Teachers Retirement System—also increased holdings. Institutions collectively own 95.70% of XRAY.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) has been assigned an average recommendation of "Hold" from the fifteen brokerages that are presently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $13.5385.

A number of equities analysts have recently weighed in on XRAY shares. Barrington Research set a $15.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, August 10th. Weiss Ratings restated a "sell (e+)" rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. BMO Capital Markets reaffirmed a "market perform" rating and issued a $13.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, August 7th. Mizuho cut their price target on DENTSPLY SIRONA from $16.00 to $14.00 and set a "neutral" rating for the company in a report on Wednesday, May 6th. Finally, Piper Sandler increased their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 29th.

Insider Activity

In other DENTSPLY SIRONA news, Director Brian P. Mckeon bought 10,000 shares of the company's stock in a transaction that occurred on Friday, June 12th. The stock was purchased at an average cost of $10.12 per share, for a total transaction of $101,200.00. Following the completion of the purchase, the director owned 10,000 shares of the company's stock, valued at $101,200. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Brian T. Gladden bought 9,985 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average price of $10.02 per share, for a total transaction of $100,049.70. Following the completion of the transaction, the director directly owned 61,849 shares of the company's stock, valued at $619,726.98. This trade represents a 19.25% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 35,160 shares of company stock valued at $351,179 over the last quarter. Company insiders own 0.46% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of XRAY. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $2,395,000. California State Teachers Retirement System increased its position in DENTSPLY SIRONA by 929.7% during the second quarter. California State Teachers Retirement System now owns 2,389,202 shares of the medical instruments supplier's stock worth $25,349,000 after purchasing an additional 2,157,171 shares during the last quarter. HB Wealth Management LLC purchased a new position in DENTSPLY SIRONA during the second quarter worth approximately $152,000. AlphaGrep UK Ltd acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at $530,000. Finally, Round Rock Advisors LLC acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at $572,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Down 3.7%

Shares of NASDAQ:XRAY opened at $10.76 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. DENTSPLY SIRONA has a 52-week low of $9.40 and a 52-week high of $14.86. The stock's fifty day simple moving average is $12.13 and its 200-day simple moving average is $11.69. The company has a market capitalization of $2.15 billion, a P/E ratio of -3.91, a P/E/G ratio of 1.42 and a beta of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The firm had revenue of $898.00 million during the quarter, compared to analysts' expectations of $889.93 million. During the same quarter last year, the business posted $0.52 EPS. The firm's quarterly revenue was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, equities research analysts forecast that DENTSPLY SIRONA will post 1.4 earnings per share for the current fiscal year.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc NASDAQ: XRAY is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company's product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source